179 related articles for article (PubMed ID: 31081803)
1. Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance.
Pan C; Jin L; Wang X; Li Y; Chun J; Boese AC; Li D; Kang HB; Zhang G; Zhou L; Chen GZ; Saba NF; Shin DM; Magliocca KR; Owonikoko TK; Mao H; Lonial S; Kang S
J Clin Invest; 2019 May; 129(6):2431-2445. PubMed ID: 31081803
[TBL] [Abstract][Full Text] [Related]
2. EFHD2 contributes to non-small cell lung cancer cisplatin resistance by the activation of NOX4-ROS-ABCC1 axis.
Fan CC; Tsai ST; Lin CY; Chang LC; Yang JC; Chen GY; Sher YP; Wang SC; Hsiao M; Chang WC
Redox Biol; 2020 Jul; 34():101571. PubMed ID: 32446175
[TBL] [Abstract][Full Text] [Related]
3. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
[TBL] [Abstract][Full Text] [Related]
4. NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance.
Shanmugasundaram K; Nayak BK; Friedrichs WE; Kaushik D; Rodriguez R; Block K
Nat Commun; 2017 Oct; 8(1):997. PubMed ID: 29051480
[TBL] [Abstract][Full Text] [Related]
5. NADPH Oxidase NOX4 Is a Critical Mediator of BRAF
Azouzi N; Cailloux J; Cazarin JM; Knauf JA; Cracchiolo J; Al Ghuzlan A; Hartl D; Polak M; Carré A; El Mzibri M; Filali-Maltouf A; Al Bouzidi A; Schlumberger M; Fagin JA; Ameziane-El-Hassani R; Dupuy C
Antioxid Redox Signal; 2017 May; 26(15):864-877. PubMed ID: 27401113
[TBL] [Abstract][Full Text] [Related]
6. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib.
Wang L; Arras J; Katsha A; Hamdan S; Belkhiri A; Ecsedy J; El-Rifai W
Mol Oncol; 2017 Aug; 11(8):981-995. PubMed ID: 28417568
[TBL] [Abstract][Full Text] [Related]
8. Effect of the actin- and calcium-regulating activities of ITPKB on the metastatic potential of lung cancer cells.
Bäder S; Glaubke E; Grüb S; Muhs S; Wellbrock J; Nalaskowski M; Lange T; Windhorst S
Biochem J; 2018 Jun; 475(12):2057-2071. PubMed ID: 29871874
[TBL] [Abstract][Full Text] [Related]
9. Hsp90B enhances MAST1-mediated cisplatin resistance by protecting MAST1 from proteosomal degradation.
Pan C; Chun J; Li D; Boese AC; Li J; Kang J; Umano A; Jiang Y; Song L; Magliocca KR; Chen ZG; Saba NF; Shin DM; Owonikoko TK; Lonial S; Jin L; Kang S
J Clin Invest; 2019 Oct; 129(10):4110-4123. PubMed ID: 31449053
[TBL] [Abstract][Full Text] [Related]
10. BIAM switch assay coupled to mass spectrometry identifies novel redox targets of NADPH oxidase 4.
Löwe O; Rezende F; Heidler J; Wittig I; Helfinger V; Brandes RP; Schröder K
Redox Biol; 2019 Feb; 21():101125. PubMed ID: 30716538
[TBL] [Abstract][Full Text] [Related]
11. The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression.
Peñuelas-Haro I; Espinosa-Sotelo R; Crosas-Molist E; Herranz-Itúrbide M; Caballero-Díaz D; Alay A; Solé X; Ramos E; Serrano T; Martínez-Chantar ML; Knaus UG; Cuezva JM; Zorzano A; Bertran E; Fabregat I
Hepatology; 2023 Aug; 78(2):416-433. PubMed ID: 35920301
[TBL] [Abstract][Full Text] [Related]
12. NOX4 Signaling Mediates Cancer Development and Therapeutic Resistance through HER3 in Ovarian Cancer Cells.
Liu WJ; Huang YX; Wang W; Zhang Y; Liu BJ; Qiu JG; Jiang BH; Liu LZ
Cells; 2021 Jun; 10(7):. PubMed ID: 34209278
[TBL] [Abstract][Full Text] [Related]
13. Nox4 is a Target for Tuberin Deficiency Syndrome.
Shi Q; Viswanadhapalli S; Friedrichs WE; Velagapudi C; Szyndralewiez C; Bansal S; Bhat MA; Choudhury GG; Abboud HE
Sci Rep; 2018 Feb; 8(1):3781. PubMed ID: 29491408
[TBL] [Abstract][Full Text] [Related]
14. Inositol 1,4,5-trisphosphate 3-kinase B is a negative regulator of BCR signaling that controls B cell selection and tolerance induction.
Miller AT; Beisner DR; Liu D; Cooke MP
J Immunol; 2009 Apr; 182(8):4696-704. PubMed ID: 19342645
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin resistance in lung cancer is mediated by MACC1 expression through PI3K/AKT signaling pathway activation.
Zhang Q; Zhang B; Sun L; Yan Q; Zhang Y; Zhang Z; Su Y; Wang C
Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):748-756. PubMed ID: 29961813
[TBL] [Abstract][Full Text] [Related]
16. Nrf2 mediates redox adaptation in NOX4-overexpressed non-small cell lung cancer cells.
Wu Q; Yao B; Li N; Ma L; Deng Y; Yang Y; Zeng C; Yang Z; Liu B
Exp Cell Res; 2017 Mar; 352(2):245-254. PubMed ID: 28196727
[TBL] [Abstract][Full Text] [Related]
17. Nox4 inhibition enhances the cytotoxicity of cisplatin in human renal cancer cells.
Chang G; Chen L; Lin HM; Lin Y; Maranchie JK
J Exp Ther Oncol; 2012; 10(1):9-18. PubMed ID: 22946340
[TBL] [Abstract][Full Text] [Related]
18. ROS-regulated phosphorylation of ITPKB by CAMK2G drives cisplatin resistance in ovarian cancer.
Li J; Zheng C; Wang M; Umano AD; Dai Q; Zhang C; Huang H; Yang Q; Yang X; Lu J; Pan W; Li B; Yao S; Pan C
Oncogene; 2022 Feb; 41(8):1114-1128. PubMed ID: 35039634
[TBL] [Abstract][Full Text] [Related]
19. IP3 3-kinase B controls hematopoietic stem cell homeostasis and prevents lethal hematopoietic failure in mice.
Siegemund S; Rigaud S; Conche C; Broaten B; Schaffer L; Westernberg L; Head SR; Sauer K
Blood; 2015 Apr; 125(18):2786-97. PubMed ID: 25788703
[TBL] [Abstract][Full Text] [Related]
20. Inositol trisphosphate 3-kinase B is increased in human Alzheimer brain and exacerbates mouse Alzheimer pathology.
Stygelbout V; Leroy K; Pouillon V; Ando K; D'Amico E; Jia Y; Luo HR; Duyckaerts C; Erneux C; Schurmans S; Brion JP
Brain; 2014 Feb; 137(Pt 2):537-52. PubMed ID: 24401760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
